545 related articles for article (PubMed ID: 6755239)
1. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
2. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
Rashid KA; Babish JG; Johnson BE; Mumma RO
Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
[TBL] [Abstract][Full Text] [Related]
3. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
4. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
Iba MM
Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
[TBL] [Abstract][Full Text] [Related]
5. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
Milling DM; Maddock MB
Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of furoquinoline alkaloids in the Salmonella/microsome assay. Mutagenicity of dictamnine is modified by various enzyme inducers and inhibitors.
Häfele F; Schimmer O
Mutagenesis; 1988 Jul; 3(4):349-53. PubMed ID: 3062325
[TBL] [Abstract][Full Text] [Related]
7. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
8. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
9. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
[TBL] [Abstract][Full Text] [Related]
13. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
Alldrick AJ; Rowland IR
Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
[TBL] [Abstract][Full Text] [Related]
14. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
Kevekordes S; Porzig J; Gebel T; Dunkelberg H
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
[TBL] [Abstract][Full Text] [Related]
15. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
Traynor CA; Shane BS; Hajos AK; Winston GW
Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
Smith JN; Ioannides C
Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
[TBL] [Abstract][Full Text] [Related]
17. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
Mori Y; Niwa T; Toyoshi K
Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
[TBL] [Abstract][Full Text] [Related]
18. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
Shah AB; Combes RD; Rowland IR
Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
[TBL] [Abstract][Full Text] [Related]
19. Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test.
Baker RS; Bonin AM; Stupans I; Holder GM
Mutat Res; 1980 Jun; 71(1):43-52. PubMed ID: 6993931
[TBL] [Abstract][Full Text] [Related]
20. Effects of metyrapone on microsomal-dependent Salmonella mutagenesis. Studies with chloroallyl ethers and model compounds.
Distlerath LM; Loper JC; Tabor MW
Biochem Pharmacol; 1983 Dec; 32(24):3739-48. PubMed ID: 6661250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
